Background-In myocardial ischemia, induction of autophagy via the AMP-induced protein kinase pathway is protective, whereas reperfusion stimulates autophagy with BECLIN-1 upregulation and is implicated in causing cell death. We examined flux through the macroautophagy pathway as a determinant of the discrepant outcomes in cardiomyocyte cell death in this setting. Methods and Results-Reversible left anterior descending coronary artery ligation was performed in mice with cardiomyocyte-restricted expression of green fluorescent protein-tagged microtubule-associated protein light chain-3 to induce ischemia (120 minutes) or ischemia/reperfusion (30 -90 minutes) with saline or chloroquine pretreatment (nϭ4 per group). Autophagosome clearance, assessed as the ratio of punctate light chain-3 abundance in saline to chloroquine-treated samples, was markedly impaired with ischemia/reperfusion compared with sham controls. Reoxygenation increased cell death in neonatal rat cardiomyocytes compared with hypoxia alone, markedly increased autophagosomes but not autolysosomes (assessed as punctate dual fluorescent mCherry-green fluorescent protein tandem-tagged light chain-3 expression), and impaired clearance of polyglutamine aggregates, indicating impaired autophagic flux. The resultant autophagosome accumulation was associated with increased reactive oxygen species and mitochondrial permeabilization, leading to cell death, which was attenuated by cyclosporine A pretreatment. Hypoxia-reoxygenation injury was accompanied by reactive oxygen species-mediated BECLIN-1 upregulation and a reduction in lysosome-associated membrane protein-2, a critical determinant of autophagosome-lysosome fusion. Restoration of lysosome-associated membrane protein-2 levels synergizes with partial BECLIN-1 knockdown to restore autophagosome processing and to attenuate cell death after hypoxia-reoxygenation.
Clinical Perspective on p 3181
Autophagy induction is critical for survival during the perinatal period of relative starvation, 5 and suppression of constitutive cardiomyocyte autophagy with ablation of ATG5 6 or impairment of late stages of autophagy in the absence of lysosome-associated membrane protein-2 (LAMP2) in patients with Danon disease 7 and in mice with LAMP2 ablation 8 results in cardiomyopathy. Autophagy is also rapidly induced in the myocardium in response to stress such as fasting, 9 pressure overload, 6, 9 and ischemia/reperfusion (IR) injury. 10 In contrast to a clear prosurvival role for constitutive autophagy, stress-induced autophagy has been ascribed both salutary and deleterious roles in cardiomyocyte function and survival. 9, 10 Autophagosome prevalence, a commonly used readout for the state of autophagy activation, is determined by the rate of autophagosome formation (ie, induction of autophagy) and the rate of autophagosome destruction and is therefore a function of "flux" through the autophagic pathway. 11 It is not clear whether the increased abundance of autophagosomes in dying cells reflects upregulation of adaptive autophagy, 2, 4 an instance of dysregulated and excessive self-cannabalism, 12 or an impairment in autophagic flux with reduced clearance of autophagosomes (and presumably cargo that would normally be degraded by autophagy) as postulated to occur in Danon disease, 7 with secondary activation of programmed cell death. In this study, we have used an integrated approach to examine flux through the macroautophagy pathway in myocardial IR injury to test the hypothesis that impairment in late stages of autophagy with resultant autophagosome accumulation prevents its prosurvival role and triggers cardiomyocyte death.
Methods

IR Modeling
Adult male cardiomyocyte-specific green fluorescent protein-light chain-3 (GFP-LC3) transgenic mice 9 and C57BL/6 mice (from Jackson Laboratories) were subjected to reversible left anterior descending artery coronary ligation in the presence of chloroquine 10 mg/kg or MnTMPyP 6 mg/kg IP, respectively, or saline control 1 hour before surgery. 13 All animal studies were approved by the Animal Studies Committee at the Washington University School of Medicine and the Institutional Animal Care and Use Committee at the John Cochran VA Medical Center.
Generation of Viral Constructs
Adenoviruses coding for rat LAMP2A and rat LAMP2B were generated with the Invitrogen Virapower system. Adenoviruses coding for Beclin-1 shRNA 10 and cyan fluorescence protein-tagged polyglutamine Q19 and Q80 constructs 14 and lentivirus coding for mCherry-GFP-LC3 15 have been described.
Assessment of cell death, hypoxia-reoxygenation modeling, immunofluorescence imaging, flow cytometry, and quantitative polymerase chain reaction analysis was performed as described. 15 
Statistical Analysis
Results are expressed as meanϮSEM. Statistical differences were assessed with the unpaired Student t test for 2 independent groups, paired t test for dependent data, and 1-way ANOVA for multiple groups with SPSS software. Bonferroni post hoc testing was used after ANOVA for testing all pairwise comparisons between groups. A 2-tailed value of PϽ0.05 was considered statistically significant.
Results
Autophagosome Clearance Is Impaired in Cardiomyocytes With IR Injury In Vivo
Ischemic insult activates cardiomyocyte autophagy, as evidenced by an increase in the ratio of LC3-II to LC3-I and increased numbers of punctate GFP-LC3-bearing autophagosomes after a brief episode of myocardial ischemia. 10 Autophagosome abundance is further increased after reperfusion injury. 10 Because the prevalence of autophagosomes at any point in time is determined by the rate of formation of autophagosomes (ie, induction of autophagy) and the rate of autophagosome processing (ie, flux through the macroautophagy pathway), 11 we determined cumulative autophagic flux by determining the numbers of autophagosomes in the presence and absence of chloroquine, which inhibits lysosomal acidification and prevents autophagosome-lysosome fusion. 11 We subjected mice with cardiomyocyte-specific expression of GFP-LC3 9 to in vivo ischemia for 2 hours (confirmed by ST-segment elevation; Figure 1A , middle) or IR for an equivalent duration (ischemia for 30 minutes followed by reperfusion for 90 minutes with reversal of ST-segment elevation; Figure 1A , right) in the absence and presence of chloroquine and assessed LC3 distribution. Mice subjected to a sham procedure demonstrate a basal level of cardiomyocyte autophagy as evidenced by punctate localization of GFP-LC3 (on autophagosomes 9 ), with autophagosome accumulation (Ϸ6-fold increase) in the presence of chloroquine, suggesting intact autophagic flux ( Figure 1B and 1C ). Ischemia caused a 10-fold increase in autophagosome abundance compared with sham operation, implying the induction of autophagosome formation ( Figure 1B and 1C ). This was accompanied by partial impairment of autophagic flux (ratio of autophagosome abundance with and without chloroquine of Ϸ2 with ischemia compared with Ϸ6 in sham; Figure 1C ). Reperfusion after ischemia provoked a further increase in autophagosome abundance (23-fold), which was not altered in the presence of chloroquine, suggesting markedly impaired autophagic flux (ratio of autophagosome abundance with and without chloroquine of Ϸ1; Figure 1C ). Levels of GFPtagged LC3-II and p62, a protein that links ubiquitinated aggregates for destruction within autophagosomes and is degraded on autophagosome processing, 16 increased in IRtreated hearts to a degree comparable to that in hearts treated with chloroquine ( Figure 1D -1F), further supporting the observation of impaired autophagosome processing with IR injury.
Myocardial IR Injury Provokes a Decline in LAMP2 and an Increase in BECLIN-1 Abundance With Impaired Autophagosome Processing
Autophagosome processing can be impaired if lysosome numbers decline 15 or if there is a selective impairment in autophagosome-lysosome fusion or lysosome function. Accordingly, we examined the expression of the lysosome membrane proteins LAMP1 and LAMP2. Interestingly, the level of LAMP2 declined by 41% and of LAMP1 declined by 44% in IR-treated GFPL-LC3 transgenic hearts ( Figure  1D , 1G, and 1H); only the decline in LAMP1, which closely tracks lysosome numbers, 15 was prevented by chloroquine pretreatment, suggesting that the decline in LAMP2 was independent of lysosome pH and was not related to lysosome consumption in IR-induced autophagy. Interestingly, although LAMP1 deficiency in mice is of no serious consequence, 17 LAMP2 is a critical determinant of autophagosome-lysosome fusion, 18, 19 and mutations causing LAMP2 deficiency result in Danon disease, 7 which is characterized by autophagosome accumulation in multiple tissues, including the myocardium, and cardiomyopathy. 8 As observed previously, 10 BECLIN-1 levels were elevated with reperfusion injury and not during ischemia ( Figure 1D and 1I).
To evaluate whether a reperfusion-induced surge in reactive oxygen species (ROS) generation mediated the observed changes, we treated adult male C57BL/6 mice with Mn(III)tetrakis(1-Methyl-4-pyridyl) porphyrin pentachloride (MnTMPyP), a cell-permeable superoxide dismutase mimetic that acts as an ROS scavenger, or diluent and subjected them to reversible left anterior descending ligation for 30 minutes followed by reperfusion for 90 minutes or sham surgery. IR induced a marked increase in autophagosome-bound LC3-II abundance with p62 accumulation in the myocardium, which were both prevented by pretreatment with MnTMPyP ( Figure  2A-2C ). This suggests that IR-induced ROS generation may inhibit autophagosome processing in addition to damaging cellular structures that need removal through macroautophagy. Importantly, the observed IR-induced decline in LAMP2 and upregulation in BECLIN-1 were prevented with MnTMPyP pretreatment (Figure 2A , 2D, and 2E). Curiously, we did not observe an IR-induced decline in LAMP1 in this strain of mice, as observed in the GFL-LC3 reporter mice, and basal LAMP1 levels appeared to be negatively regulated by ROS (Figure 2A and 2F).
Impaired Autophagosome Clearance Is Sufficient to Cause Cell Death in Cardiomyocytes
Autophagy has been implicated as a mechanism for programmed cell death. 3 To test the hypothesis that impairment in autophagosome processing causes cardiomyocyte death, we subjected neonatal rat cardiomyocytes (NRCMs) to treatment with rapamycin, an irreversible inhibitor of mammalian target of rapamycin, 10 and nutrient deprivation 15 to stimulate autophagy and blocked autophagosome processing with chloroquine pretreatment. 15 The relative abundance of autophagosomes and autolysosomes was assessed with lentivirally transduced mCherry-GFP tandem-tagged LC3 ( Figure 3A ) as described previously. 15 Induction of autophagy leads to punctate localization of LC3 on autophagosomes, 9 which demonstrate both red and green fluorescence, with subsequent loss of green fluorescent signal on autophagosome-lysosome fusion and formation of autolysosomes resulting from the instability of GFP in the acidic intralysosomal environment. 15 NRCMs in culture demonstrate constitutive (basal) autophagy with a preponderance of autolysosomes (punctate dots that fluoresce only red; Figure 3A , top middle, and Figure 3B ) and a few autophagosomes (punctate dots that fluoresce green and red, ie, yellow; Figure 3A , top right, and Figure 3B ). Treatment with rapamycin stimulates autophagy with enhanced autophagic flux, 15 as evidenced by markedly increased abundance of autolysosomes without a discernible accumulation of autophagosomes ( Figure 3A , middle, and Figure 3B ). Pretreatment with chloroquine resulted in accumulation of autophagosomes and the near absence of autolysosomes ( Figure 3A , bottom, and Figure 3B ). Rapamycin treatment provoked a decline in cumulative LC3 abundance, suggesting consumption during autophagy, and clearance of p62 ( Figure 3C ) compared with control, indicating intact flux. In contrast, impairment of autophagosome processing with chloroquine caused accumulation of autophagosome-bound LC3-II and p62 ( Figure 3C ), indicating impaired autophagosome clearance, which was sufficient to cause cell death in the basal state, and with rapamycin or nutrient deprivationinitiated autophagy, wherein autophagosome clearance was inhibited ( Figure 3D ). To investigate the mechanism of cell death with chloroquine, we posited that autophagosome accumulation prevents the clearance of damaged intracellular organelles and proteins, leading to increased ROS generation, which causes mitochondrial permeabilization and activation of programmed apoptosis and/or necrosis. 3 Indeed, chloroquine treatment increased ROS generation ( Figure 3E and 3F) with loss of mitochondrial membrane potential ( Figure 3E and 3G). Induction of ROS by chloroquine was not prevented by pretreatment with cyclosporine A, an inhibitor of mitochondrial permeability transition pore, indicating that ROS generation was upstream of mitochondrial permeabilization. Accordingly, pretreatment with cyclosporine A but not ZVAD-fmk (a pancaspase inhibitor) attenuated chloroquine-induced cell death under conditions of both basal and rapamycin-stimulated autophagy, suggesting activation of programmed necrosis pathway with autophagosome accumulation.
Hypoxia-Reoxygenation Induces Autophagosome Accumulation in Cardiomyocytes
Autophagic flux has been noted to be impaired in HL-1 cardiomyocytes, an immortalized cell line derived from atrial myocytes, with in vitro hypoxia-reoxygenation insult. 20 We subjected NRCMs to in vitro hypoxia (ambient O 2 concentration Ͻ1%) followed by reoxygenation and determined the relative abundance of autophagosomes and autolysosomes. 15 NRCMs cultured in a normoxic environment display basal autophagy with intact flux ( Figure 4A ; see also Figure 3A ). Hypoxia for 24 hours markedly increased the abundance of autophagic structures ( Figure 4A , middle), with an increase in both autophagosomes and autolysosomes ( Figure 4B ). Reoxygenation after 6 hours of hypoxia further increased the numbers of autophagic structures, which are predominantly autophagosomes ( Figure 4A , bottom, and Figure IA and IB in the online-only Data Supplement), without an increase in autolysosomes. Both prolonged hypoxia and hypoxia-reoxygenation increased LC3-II abundance, indicating increased numbers of autophagosomes ( Figure 4C and Figure IC in the online-only Data Supplement) associated with a reduction in LAMP2 abundance (assessed with a monoclonal antibody directed to the matrix side of LAMP2 protein, which detects all isoforms; Figure 4C and 4D), 21 without affecting LAMP1 levels except with longer duration (72 hours) of injury ( Figure 4D ). This was not due to a decline in the numbers or distribution of lysosomes (Figures ID, Figure 4D and Figure IC in the online-only Data Supplement). Taken together, these data suggest impairment in autophagosome processing with reoxygenation after a hypoxic insult. To determine whether hypoxia-reoxygenation impairs proteasomal processing of proteins, which could result in an overload of the autophagic pathway for protein degradation and conceivably overwhelm the lysosomal machinery, we forcibly expressed polyglutamine repeats, which are known to be differentially processed via the ubiquitin- proteasome pathway (Q19) and macroautophagy (Q80), 14 in NRCMs and subjected them to hypoxia-reoxygenation injury. Hypoxia-reoxygenation impaired clearance of polyglutamine Q80 aggregates ( Figure 5A and 5B) but not Q19 ( Figure IIIA in the online-only Data Supplement), suggesting specific impairment in autophagy.
To determine whether hypoxia-reoxygenation-induced impairment in autophagosome processing contributes to cell death, we subjected NRCMs to matched durations of hypoxia and hypoxia-reoxygenation. Hypoxia increased cell death in NRCMs, with Ϸ45% of cells dead after 24 hours ( Figure 5C and 5D and Figure IIIB in the online-only Data Supplement) compared with 6% in cells cultured in normoxic conditions. Interestingly, reoxygenation after a short hypoxic insult (6 hours) increased cell death even further (52%) compared with a comparable duration of hypoxia alone, suggesting an association between impaired autophagosome processing (see Figure 4 ) and reoxygenation-induced cell death in NRCMs. Experimental inhibition of autophagosome processing with chloroquine treatment increased hypoxia-induced cell death to levels comparable to hypoxia-reoxygenation but did not affect cell death with hypoxia-reoxygenation (Figure IIIC in the online-only Data Supplement), consistent with a severe impairment in autophagosome processing in cells subjected to hypoxia-reoxygenation injury. Autophagosome accumulation with hypoxia-reoxygenation was associated with ROS generation (Figure 5E and 5F) and mitochondrial permeabilization ( Figure 5E and 5G) , and although mitochondrial permeabilization was prevented with cyclosporine A pretreatment ( Figure 5E and 5G) , ROS generation was not ( Figure 5E and 5F ), suggesting that it is upstream of mitochondrial permeabilization, mirroring the observations with chloroquine-induced autophagosome accumulation ( Figure 3E-3G ). Accordingly, cyclosporine A but not ZVAD-fmk attenuated hypoxiareoxygenation-induced cell death, suggesting a mitochon- drial permeability transition pore-driven necrotic mechanism of cell death 3 ( Figure 5H ).
Hypoxia-Reoxygenation-Induced LAMP2 Decline and BECLIN-1 Upregulation Are Mediated by ROS
The decline in LAMP2 and the increase in BECLIN-1 abundance are observed very early (2 hours) after the onset of reperfusion/reoxygenation (Figure 2A , 2D, and 2E and Figure  I in the online-only Data Supplement), suggesting a posttranslational rather than a transcriptional mechanism. As observed with in vivo IR injury, treatment with MnTMPyP to scavenge ROS prevented a reoxygenation-induced decline in LAMP2 abundance ( Figure 6A ) and attenuated the increase in BECLIN-1 abundance ( Figure 6B) , with restoration of a relative excess of autolysosomes and a decrease in total autophagic structures in NRCMs subjected to hypoxia-reoxygenation ( Figure 6C and 6D ). This suggests that the reoxygenation-induced increase in ROS provokes autophagosome formation but impairs their clearance.
Beclin-1 Knockdown Synergizes With Exogenous Expression of LAMP2 Isoforms to Restore Autophagosome Processing
Multiple studies have demonstrated the salutary effects of BECN1 haploinsufficiency in pathological states, 9, 10, 22 including reperfusion injury, 10 in contrast to its essential role in autophagosome formation, 23, 24 which is critical for autophagy-mediated cell survival. 2, 4 Whether the observed reperfusion/reoxygenation-induced increase in BECLIN-1 abundance (to supranormal levels; Figures 1D, 1I, 2A , 2E, and 4D) or the decline in LAMP2 levels ( Figures 1D, 1G , 2A, 2D, 4C, and 4D) contributes to ROS-induced impairment in autophagosome processing is not known. Accordingly, to test the hypothesis that partial knockdown of BECLIN-1 and restoration of LAMP2 by exogenous expression will synergistically restore autophagosome processing and attenuate hypoxia-reoxygenation-induced cell death, we transduced NRCMs with increasing doses of adenovirus coding for Beclin-1 shRNA expression 10 and rat LAMP2A and rat LAMP2B, the 2 cardiac-expressed isoforms of LAMP2, 25 either individually or in combination. BECLIN-1 knockdown was minimal with the low infective dose of virus (multiplicity of infection [MOI]ϭ1) and substantial with a higher dose (MOIϭ10) compared with control ( Figure 7A ). Exogenous expression of LAMP2A and LAMP2B prevented the decline in LAMP2 levels after hypoxia-reoxygenation injury ( Figure  7B and Figure IV in the online-only Data Supplement). Importantly, exogenous expression of LAMP2A and LAMP2B resulted in restoration of autophagosome processing, as indicated by reduced LC3-II and p62 accumulation (compared with respective normoxia control; Figure 7B ), and restoration of autolysosome predominance after hypoxiareoxygenation injury compared with a predominant increase in autophagosomes in cells treated with control viruses (Figure 7C and 7D) . The effects of Beclin-1 knockdown were dose dependent. Although minimal Beclin-1 knockdown (Beclin-1 shRNA MOIϭ1; Figure 7A ) restored autophagosome processing either singly, as indicated by the increased ratio of autolysosomes to autophagosomes and reduced LC3-II and p62 accumulation (compared with respective normoxia control; Figure 7A and Figure VA ure 7D and Figure VIA in the online-only Data Supplement). These data suggest that the increased levels of BECLIN-1 seen with reperfusion/reoxygenation contribute to the impairment in autophagosome clearance, whereas the basal levels of BECLIN-1 are necessary for the induction of autophagosome formation in response to hypoxia-reoxygenation injury. The restoration of autophagosome processing with partial Beclin-1 knockdown (low dose) and LAMP2A/B overexpression was individually associated with the reduction in hypoxia-reoxygenation-induced cell death, with the largest benefit (32% reduction in cell death) observed with a combination of these strategies ( Figure 7E ). Further knock-down of Beclin-1 (MOIϭ10) with a resultant inhibition of autophagosome formation ( Figure 7D and Figure VA in the online-only Data Supplement) markedly increased cell death in NRCMs cultured under normoxic conditions and in response to hypoxia-reoxygenation injury ( Figure 7E) , underscoring a critical role for autophagy in cardiomyocyte survival. 10, 20, 26 
BECLIN-1 Abundance Regulates Transcription of Autophagy Genes
In addition to the established role for BECLIN-1 in inducing autophagosome formation, our results indicate that partial Beclin-1 knockdown enhances autophagosome processing. Indeed, whereas the increased total LC3 and/or p62 abundance with partial Beclin-1 knockdown ( Figure 7A and Figure VC in the online-only Data Supplement) could indicate suppression of autophagosome formation with secondary accumulation of these proteins, the increase in the ratio of autolysosomes to autophagosomes with hypoxia-reoxygenation ( Figure 7C and Figure VA and VB in the online-only Data Supplement) suggests otherwise. Therefore, we examined the serial changes in protein and transcript abundance of LC3 and p62, along with that of LAMP1, the levels of which track lysosome numbers 15 and do not change with hypoxiareoxygenation injury ( Figure 4D) , and RAB7, a small GTP binding protein that mediates autophagosome-lysosome fusion, 27 with Beclin-1 knockdown (with a low viral dose of MOIϭ1). Interestingly, partial Beclin-1 knockdown increased total LC3, p62, LAMP1, and RAB7 abundance at 48 and 72 hours ( Figure 8A ) compared with nontargeting LacZ shRNA-transduced cells, which was preceded or accompanied by an increase in respective gene transcripts, followed by a suppression in transcript levels at 72 hours for MAP1LC3B, LAMP1, and RAB7 but not SQSTM1 (Figure 8B-8E) . These observations suggest that Beclin-1 knockdown activates the transcriptional machinery early (on or before 48 hours) to increase the synthesis of autophagy and lysosomal proteins, which is subsequently suppressed (at 72 hours) when levels of these proteins build up, suggesting a mechanism for restoring flux by priming the autophagy pathway. 15 Indeed, exogenous expression of BECLIN-1 for 48 hours stimulated autophagosome formation but impaired autophagosome pro- cessing (Figure 8F and 8G ) and increased levels of autophagosome-bound LC3-II and p62 with a decline in LAMP1 and RAB7 levels ( Figure 8H ) in a dose-dependent fashion. Importantly, high levels of BECLIN-1 expression (MOIϭ100) suppressed gene transcription (predating the observed protein changes) for MAP1LC3B ( Figure 8I ), LAMP1 ( Figure 8K ), and RAB7 ( Figure 8L ) but not SQSTMI ( Figure 8J ) and increased cell death ( Figure 8M ). BECLIN-1 protein levels thus appear to be a "sensor" for transcriptional priming of the cellular autophagic machinery and an important cellular control point for dictating relative abundance of relevant autophagy-lysosomal proteins. Taken together, these data suggest that the ROS-induced increase in BECLIN-1 abundance could suppress autophagosome maturation via transcriptional downregulation of components of the autophagy-lysosome machinery.
Discussion
In this study, we demonstrate that in IR injury, cardiomyocyte autophagy is upregulated as a stress-response mechanism but autophagosome clearance is impaired, contributing to cell death. Specifically, we found a rapid reperfusion-induced decline in LAMP2, a protein critical for autophagosome-lysosome fusion, and upregulation of BECLIN-1, which impairs autophagosome processing, with increased ROS generation and mitochondrial permeabilization, thereby provoking cardiomyocyte death. Facilitating autophagosome processing by restoring LAMP2 levels and partially knocking down BECLIN-1 restores autophagosome processing and attenuates reoxygenation-induced cell death.
Contemporary studies in cardiomyocytes subjected to hypoxia-reoxygenation have demonstrated the accumulation of autophagosomes, 20 LC3-II, and p62 10,28 and a decline in nicotinamide phosphoribosyltransferase, which impairs autophagosome processing, 28 indicating impaired "autophagic flux" in vitro. Conversely, increases in both autophagosomes and autolysosomes (as indicated by mRFP-GFP LC3) 29 were interpreted as "intact" flux in vivo. These discrepant observations reflect the limitations of various imperfect tools to monitor flux through the autophagy pathway. Indeed, the lack of equivalent fluorescence intensity and photostability of mRFP and GFP use in the dual fluorescent construct 29 and differential kinetics of GFP degradation, depending on the state of lysosome acidification, 30 may account for the variable readouts. We have attempted to overcome these limitations by generating an LC3 construct tandem tagged with mCherry and GFP probes, which have comparable intensities and photostability, 31 ruling out alterations in lysosomal acidification, and using complementary approaches permitting increased accuracy in the assessment of autophagic flux.
Our results explain why autophagy, which facilitates cardiomyocyte survival (with reduced infarct size) during ischemia, 10, 32 has been implicated in causing cell death (with increased infarct size) on reperfusion of the ischemic myocardium. 10 In the study by Matsui et al 10 , reperfusion provoked a 7-fold increase in autophagosome abundance in the absence of further AMP-induced protein kinase activation or mammalian target of rapamycin inhibition during the ische-mic phase. Importantly, reperfusion was associated with a rapid upregulation of BECLIN-1 (within 30 minutes), and BECN1 haploinsufficient mice demonstrated a decrease in cardiomyocyte autophagosome abundance, reduced programmed cell death, and reduced infarct size with in vivo IR injury compared with wild-type controls. The assumption that BECN1 haploinsufficiency leads to a reduction in autophagosome abundance primarily by preventing autophagy initiation is challenged by our results that demonstrate that it increased autophagosome processing, ie, increased autophagic flux, likely by relieving the transcriptional downregulation of the autophagy-lysosome machinery by supranormal BECLIN-1 levels, while enough BECLIN-1 protein is available to facilitate autophagosome formation (Figure 8) . A more complete knockdown of BECLIN-1, however, impairs autophagosome formation, thereby impairing autophagy, with increased cardiomyocyte death. Beclin-1 knockdown may also restore autophagosome processing by interrupting the interaction with Rubicon, a GTPase-regulating protein that localizes to late endosome/autophagosomes and inhibits autophagic flux. 33 The observation that Beclin-1 knockdown confers benefit above and beyond that with LAMP2 overexpression, despite restoration of autophagy to a similar extent ( Figure 7C and 7D) , suggests that other mechanisms such as a reduction in p53 levels 34 or restoration of mitochondrial homeostasis 22 could be operative. Interestingly, the possibility that Beclin-1 knockdown may upregulate transcription of LAMP2 may explain the very similar degree of benefit obtained with Beclin-1 knockdown alone versus in combination with LAMP2A ϩ2B overexpression ( Figure 7E ). Thus, BECLIN-1 abundance may act as a switch to determine whether the end result of autophagy is efficient autophagic degradation of targeted cargo to ensure cellular homeostasis and survival or autophagosome accumulation, triggering programmed cell death. Such a role for BECLIN-1 is consistent with the observation that it acts as tumor suppressor protein. 23, 24 A novel observation of this study is the rapid decline in LAMP2 abundance with reperfusion. LAMP2 is a critical determinant of autophagosome-lysosome fusion. 18, 19 LAMP2 knockdown impairs autophagy in nutrient-starved adult rat ventricular myocytes and causes cell death at levels comparable to autophagy inhibition with 3MA; 26 and ablation of LAMP2 8 or loss of LAMP2 protein owing to mutations in individuals with Danon disease 7 causes cardiomyocyte autophagosome accumulation and extensive myocardial fibrosis, 35 suggesting cell death as the pathogenic mechanism. Interestingly, exogenous expression of both LAMP2A, a protein receptor for chaperone-mediated autophagy, 36 and LAMP2B, which is postulated to be involved in autophagosome-lysosome fusion, 7,18 accelerated autophagosome processing, suggesting a redundant role for these isoforms in the heart.
Given the exploratory nature of the study, the type I error rate was not controlled across multiple experimental outcomes, which would require additional studies focusing on specific associations. Nevertheless, our results, which require confirmation in adult cardiac myocytes and the in vivo heart, suggest that impaired autophagosome clearance results in increased ROS levels, which trigger mitochondrial permeabilization, leading to a necrotic mechanism of cell death in cardiac IR injury, and underscore the need for careful evaluation of autophagic flux to determine its role in cardiac stress and physiology.
